PT  - JOURNAL ARTICLE
AU  - Thibord, Florian
AU  - Klarin, Derek
AU  - Brody, Jennifer A.
AU  - Chen, Ming-Huei
AU  - Levin, Michael G.
AU  - Chasman, Daniel I.
AU  - Goode, Ellen L.
AU  - Hveem, Kristian
AU  - Teder-Laving, Maris
AU  - Martinez-Perez, Angel
AU  - Aïssi, Dylan
AU  - Daian-Bacq, Delphine
AU  - Ito, Kaoru
AU  - Natarajan, Pradeep
AU  - Lutsey, Pamela L.
AU  - Nadkarni, Girish N.
AU  - Cuellar-Partida, Gabriel
AU  - Wolford, Brooke N.
AU  - Pattee, Jack W.
AU  - Kooperberg, Charles
AU  - Braekkan, Sigrid K.
AU  - Li-Gao, Ruifang
AU  - Saut, Noemie
AU  - Sept, Corriene
AU  - Germain, Marine
AU  - Judy, Renae L.
AU  - Wiggins, Kerri L.
AU  - Ko, Darae
AU  - O’Donnell, Christopher
AU  - Taylor, Kent D.
AU  - Giulianini, Franco
AU  - De Andrade, Mariza
AU  - Nøst, Therese H.
AU  - Boland, Anne
AU  - Empana, Jean-Philippe
AU  - Koyama, Satoshi
AU  - Gilliland, Thomas
AU  - Do, Ron
AU  - Wang, Xin
AU  - Zhou, Wei
AU  - Soria, Jose Manuel
AU  - Souto, Juan Carlos
AU  - Pankratz, Nathan
AU  - Haessler, Jeffery
AU  - Hindberg, Kristian
AU  - Rosendaal, Frits R.
AU  - Turman, Constance
AU  - Olaso, Robert
AU  - Kember, Rachel L.
AU  - Bartz, Traci M.
AU  - Lynch, Julie A.
AU  - Heckbert, Susan R.
AU  - Armasu, Sebastian M.
AU  - Brumpton, Ben
AU  - Smadja, David M.
AU  - Jouven, Xavier
AU  - Komuro, Issei
AU  - Clapham, Katharine
AU  - Loos, Ruth J.F.
AU  - Willer, Cristen
AU  - Sabater-Lleal, Maria
AU  - Pankow, James S.
AU  - Reiner, Alexander P.
AU  - Morelli, Vania M.
AU  - Ridker, Paul M.
AU  - van Hylckama Vlieg, Astrid
AU  - Deleuze, Jean-François
AU  - Kraft, Peter
AU  - Rader, Daniel J.
AU  - McKnight, Barbara
AU  - ,
AU  - ,
AU  - ,
AU  - Lee, Kyung Min
AU  - Psaty, Bruce M.
AU  - Skogholt, Anne Heidi
AU  - Emmerich, Joseph
AU  - Suchon, Pierre
AU  - Japan, Biobank
AU  - Rich, Stephen S.
AU  - Vy, Ha My T.
AU  - Tang, Weihong
AU  - Jackson, Rebecca D.
AU  - Hansen, John-Bjarne
AU  - Morange, Pierre-Emmanuel
AU  - Kabrhel, Christopher
AU  - Trégouët, David-Alexandre
AU  - Damrauer, Scott
AU  - Johnson, Andrew D.
AU  - Smith, Nicholas L.
TI  - Cross-Ancestry Investigation of Venous Thromboembolism Genomic Predictors
AID  - 10.1101/2022.03.04.22271003
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.03.04.22271003
4099  - http://medrxiv.org/content/early/2022/03/08/2022.03.04.22271003.short
4100  - http://medrxiv.org/content/early/2022/03/08/2022.03.04.22271003.full
AB  - Venous thromboembolism (VTE) is a complex disease with environmental and genetic determinants. We present new cross-ancestry meta-analyzed genome-wide association study (GWAS) results from 30 studies, with replication of novel loci and their characterization through in silico genomic interrogations. In our initial genetic discovery effort that included 55,330 participants with VTE (47,822 European, 6,320 African, and 1,188 Hispanic ancestry), we identified 48 novel associations of which 34 replicated after correction for multiple testing. In our combined discovery-replication analysis (81,669 VTE participants) and ancestry-stratified meta-analyses (European, African and Hispanic), we identified another 44 novel associations, which are new candidate VTE-associated loci requiring replication. In total, across all GWAS meta-analyses, we identified 135 independent genomic loci significantly associated with VTE risk. We also identified 31 novel transcript associations in transcriptome-wide association studies and 8 novel candidate genes with protein QTL Mendelian randomization analyses. In silico interrogations of hemostasis and hematology traits and a large phenome-wide association analysis of the 135 novel GWAS loci provided insights to biological pathways contributing to VTE, indicating that some loci may contribute to VTE through well-characterized coagulation pathways while others provide new data on the role of hematology traits, particularly platelet function. Many of the replicated loci are outside of known or currently hypothesized pathways to thrombosis. In summary, these findings highlight new pathways to thrombosis and provide novel molecules that may be useful in the development of antithrombosis treatments with reduced risk of bleeds.Competing Interest StatementB.M.P. serves on the Steering Committee of the Yale Open Data Access Project funded by Johnson & Johnson. P.M.R. has received investigator initiated research grant support for unrelated projects from NHLBI, Operation Warp Speed, Novartis, Kowa, Amarin, and Pfizer; and has served as a consultant on unrelated issues to Novo Nordisk, Flame, Agepha, Uppton, Novartis, Jansen, Health Outlook, Civi Biopharm, Alnylam, and SOCAR. P.N. reports grants from Amgen, Apple, AstraZeneca, Boston Scientific, and Novartis, personal fees from Apple, AstraZeneca, Blackstone Life Sciences, Foresite Labs, Genentech / Roche, Novartis, and TenSixteen Bio, equity in geneXwell, TenSixteen Bio, and Zizi, co-founder of TenSixteen Bio, and spousal employment at Vertex, all unrelated to the present work. G.C-P and X.W are employed by and hold stock or stock options in 23andMe, Inc. The spouse of C.J.W. works at Regeneron Pharmaceuticals.Funding StatementThe INVENT Consortium is supported in part by HL134894 and HL154385. The Analysis Commons was funded by R01HL131136. Infrastructure for the CHARGE Consortium is supported in part by the National Heart, Lung, and Blood Institute grant R01HL105756. Please refer to Supplementary Methods, Acknowledgment section, for information regarding funding of individual studies involved in this meta-analysis.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Details for each study are available in the Ethical Oversight section of the Supplemental Methods.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors